Melatonin Identified as a Potential Therapeutic Agent For SLC26A2-Related Chondrodysplasias
Melatonin Identified as a Potential Therapeutic Agent For SLC26A2-Related Chondrodysplasias
Published: 03/06/2025
Published: 03/06/2025
Melatonin Identified as a Potential Therapeutic Agent For SLC26A2-Related Chondrodysplasias